Evidence map›Paper›PMID 22308518›Full record

GuidelineJournal of the National Comprehensive Cancer Network : JNCCN2012

Lung cancer screening.

Douglas E Wood, George A Eapen, David S Ettinger, Lifang Hou, David Jackman, Ella Kazerooni, Donald Klippenstein, Rudy P Lackner, Lorriana Leard, Ann N C Leung and 16 more

Abstract readPractice Guideline
In one paragraph

Guideline in Journal of the National Comprehensive Cancer Network : JNCCN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018
    Guideline
  3. Guideline
  4. Guideline
  5. Guideline
  6. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Impact of lung cancer screening results on smoking cessation.Journal of the National Cancer Institute · 2014
    Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Douglas E WoodUniversity of Washington/Seattle Cancer Care Alliance, USA.
George A Eapen
David S Ettinger
Lifang Hou
David Jackman
Ella Kazerooni
Donald Klippenstein
Rudy P Lackner
Lorriana Leard
Ann N C Leung
Pierre P Massion
Bryan F Meyers
Reginald F Munden
Gregory A Otterson
Kimberly Peairs
Sudhakar Pipavath
Christie Pratt-Pozo
Chakravarthy Reddy
Mary E Reid
Arnold J Rotter
Matthew B Schabath
Lecia V Sequist
Betty C Tong
William D Travis
Michael Unger
Stephen C Yang

Funding

Validation of Biomarkers of Risk for the Early Detection of Lung CancerU01CA152662 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEPPEN, STEPHEN, GROGAN, ERIC L · 2010 to 2025
$12.8M
NCI NIH HHS U01 CA152662
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Detection of CancerHumansLung Neoplasms

Identifiers

PMID22308518
PMCPMC6467530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.